Stay updated on Uproleselan with Chemotherapy for AML Clinical Trial
Sign up to get notified when there's something new on the Uproleselan with Chemotherapy for AML Clinical Trial page.
Latest updates to the Uproleselan with Chemotherapy for AML Clinical Trial page
- Check4 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.1%
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedDifference0.1%
- Check25 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.2%
- Check32 days agoNo Change Detected
- Check39 days agoChange DetectedThe website has removed the 'Last Update Posted (Estimated)' and now features a definitive 'Last Update Posted' section.SummaryDifference0.0%
- Check40 days agoChange DetectedThe trial has been terminated due to failure to meet the primary endpoint, with the last update posted on July 26, 2024.SummaryDifference1%
- Check47 days agoChange DetectedThe study has expanded to 70 locations and has been updated to revision v2.10.0, replacing the previous revision v2.9.7.SummaryDifference0.4%
Stay in the know with updates to Uproleselan with Chemotherapy for AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Uproleselan with Chemotherapy for AML Clinical Trial page.